Filing Details
- Accession Number:
- 0001225208-13-024365
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-27 16:35:45
- Reporting Period:
- 2013-11-26
- Filing Date:
- 2013-11-27
- Accepted Time:
- 2013-11-27 16:35:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1224108 | D Jeffrey Capello | One Boston Scientific Place Natick MA 01760-1537 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-26 | 42,183 | $6.28 | 189,630 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-26 | 4,518 | $6.91 | 194,148 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-26 | 85,106 | $11.82 | 109,042 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-26 | 42,183 | $0.00 | 42,183 | $6.28 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-26 | 4,518 | $0.00 | 4,518 | $6.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 126,552 | 2022-02-27 | No | 4 | M | Direct | |
| 39,936 | 2021-05-12 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $11.8000 to $11.8401, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on May 12, 2012, the first anniversary of the date of grant.
Billionaire Hedge Funds
